Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Concin

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Breast Cancer Research and Treatment|June 5, 2003
Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell linesNicole Concin, Christa Zeillinger, Dan Tong, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 10, 2007
Mineral oil paraffins in human body fat and milkNicole Concin, Gerda Hofstetter, Barbara Plattner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 17, 2012
The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancerGerda Hofstetter, Astrid Berger, Regina Berger, et al.
Anticancer Research|March 16, 2016
Role of IGF-I in Primary Ovarian Cancer - A Study of the OVCAD European ConsortiumIrena Rohr, Robert Zeillinger, Michaela Heinrich, et al.
BMC Cancer|February 17, 2016
Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancerGabriel Schmid, Sara Notaro, Daniel Reimer, et al.
Journal of Women'S Health (2002)|October 6, 2011
Evidence for cosmetics as a source of mineral oil contamination in womenNicole Concin, Gerda Hofstetter, Barbara Plattner, et al.
Cancers|May 13, 2023
Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma PatientsMajdi Imterat, Philipp Harter, Kerstin Rhiem, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 8, 2011
Clinical relevance of TAp73 and ΔNp73 protein expression in ovarian cancer: a series of 83 cases and review of the literatureGerda Hofstetter, Astrid Berger, Martina Chamson, et al.
Cancers|February 11, 2023
Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian CancerFlorian Heitz, Beyhan Ataseven, Claudia Staniczok, et al.
The Lancet. Oncology|July 3, 2020
ESGO-SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancersCristiana Sessa, Dominik T Schneider, François Planchamp, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Breast Cancer Research and Treatment|June 5, 2003
Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell linesNicole Concin, Christa Zeillinger, Dan Tong, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 10, 2007
Mineral oil paraffins in human body fat and milkNicole Concin, Gerda Hofstetter, Barbara Plattner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 17, 2012
The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancerGerda Hofstetter, Astrid Berger, Regina Berger, et al.
Anticancer Research|March 16, 2016
Role of IGF-I in Primary Ovarian Cancer - A Study of the OVCAD European ConsortiumIrena Rohr, Robert Zeillinger, Michaela Heinrich, et al.
BMC Cancer|February 17, 2016
Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancerGabriel Schmid, Sara Notaro, Daniel Reimer, et al.
Journal of Women'S Health (2002)|October 6, 2011
Evidence for cosmetics as a source of mineral oil contamination in womenNicole Concin, Gerda Hofstetter, Barbara Plattner, et al.
Cancers|May 13, 2023
Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma PatientsMajdi Imterat, Philipp Harter, Kerstin Rhiem, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 8, 2011
Clinical relevance of TAp73 and ΔNp73 protein expression in ovarian cancer: a series of 83 cases and review of the literatureGerda Hofstetter, Astrid Berger, Martina Chamson, et al.
Cancers|February 11, 2023
Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian CancerFlorian Heitz, Beyhan Ataseven, Claudia Staniczok, et al.
The Lancet. Oncology|July 3, 2020
ESGO-SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancersCristiana Sessa, Dominik T Schneider, François Planchamp, et al.
Pageof 14